Introduction
Glucose is a major source of energy for cellular activity in the living body. It is crucial to maintain a proper concentration of glucose in the blood, and the homeostatic system in human physiology (e.g., nerves and the endocrine system) tightly regulates the glucose level. [1] However, some patients suffer functionalization techniques, and electrochemical analysis methods. A number of glucose monitoring methods have been developed for noninvasive glucose monitoring as well as direct blood glucose monitoring, making patient-friendly diabetes management possible.
In this review, we scrutinize the glucose sensors based on electrochemical analysis from the perspectives of materials, mode of sensing, and device designs to provide insights into the currently available technology for blood glucose monitoring. We examine the glucose sensors according to generations, whose classification is based on the principles of the enzymatic glucose reaction. Based on such principles, key considerations in the development of glucose monitoring systems are also discussed. Considering the growing interest in painless and continuous monitoring of blood glucose, we first recapitulate the established systems for blood glucose monitoring and then highlight the latest progress in noninvasive methods. This review concludes with a brief discussion of the outlook for painless noninvasive glucose monitoring systems for efficient next-generation diabetic care.
Blood Glucose Monitoring Systems
Diabetes mellitus is often attributed to a malfunction of the pancreas, preventing it from producing sufficient amount of insulin (Type I), or to abnormal cells that do not react to or even resist insulin (Type II). [24, 25] Both pathophysiological conditions may result in chronic hyperglycemia, which results in a number of metabolic abnormalities. If hyperglycemia persists, it may cause tissue damage and organ failure, leading to various complications and even increasing the mortality rate. Therefore, continuous monitoring of blood glucose levels and timely medical intervention are important for diabetic patients. Moreover, accurate measurement of the blood glucose level is important because unwanted hypoglycemia due to overdosed diabetic drugs from inaccurate blood glucose readings can cause fatal ramifications such as sudden cardiac death.
Various types of enzyme-based electrochemical glucose sensors have been developed for glucose monitoring (Figure 1) . The direct detection of glucose in the blood (invasive glucose monitoring) is the most accurate method, and there has been extensive development of detection kits for blood glucose, especially in portable or implantable forms (Figure 1, left) . [22, [26] [27] [28] For portable glucometers, a disposable strip is connected to the glucometer, and the blood drawn using a needle is collected in the strip to analyze the blood glucose level. This method is widely used because the device is simple and easy to use and the measurement of blood glucose takes place immediately. However, this point-of-care measurement does not provide a fully continuous profile of glucose levels, and it is prone to neglect abrupt spikes in blood glucose concentrations between measurements. In clinics, an implantable glucose sensor is also employed. Although the embedded sensor is more invasive and susceptible to biofouling, [29, 30] it delivers continuous measurements of glucose levels. Furthermore, an implantable sensor increases the accuracy and clinical relevance of the data as it detects glucose in the intravenous blood rather than in the peripheral blood. Although these blood-based monitoring systems have been established, diabetic patients are still not always compliant with the protocol because of the pain and inconvenience associated with the invasive detection process. [11] In the case of Type I diabetes, a large proportion of pediatric patients are especially reluctant to the needle-pricking step necessary for blood-based glucometers. [31] An alternative method for painless and noninvasive monitoring of glucose levels is urgently needed.
Biological fluids such as tears, [32] [33] [34] [35] [36] [37] saliva, [38] [39] [40] [41] interstitial fluid (ISF), [42] [43] [44] [45] [46] and sweat [47] [48] [49] [50] [51] can be obtained noninvasively or at least minimally invasively, and they contain glucose at concentrations that correlate with that in blood. Because of this correlation, these alternative biofluids have become novel analytes of interest for the painless monitoring of glucose in the body (Figure 1, right) . However, various considerations are needed to safeguard the accuracy and quality of measurements of glucose concentrations from these biofluids. Among the major considerations, the glucose level in these biofluids is lower than that in blood. To be specific, the concentration range of glucose is 2-40 × 10 −3 m in blood, 1.99-22.2 × 10 −3 m in ISF, 0.008-1.77 × 10 −3 m in saliva, 0.01-1.11 × 10 −3 m in sweat, and 0.05-5 × 10 −3 m in tears. [52] [53] [54] Therefore, optimized designs for monitoring systems specific to each of the biofluidic analytes must be developed. In the case of tears, the interference from impurities is relatively small but there are challenges associated with the energy supply for the glucose sensor on the contact lens to operate autonomously and transmit data wirelessly. In the case of saliva, the analyte is easily collected by spitting, but the large amount of impurities in saliva makes it difficult to isolate the inherent level of glucose from the fluid. In the case of ISF, a novel design for a continuous glucose monitoring system has been proposed, but it requires the subcutaneous injection of a needle, which can be uncomfortable to its prospective users. To overcome these drawbacks, wearable devices using iontophoresis or reverse iontophoresis on the skin have been introduced for the noninvasive monitoring of glucose in ISF, but further development is still needed. In the case of sweat, a monitoring system is widely applicable and easily accessible, but accompanies a disadvantage that the patient is required to sweat at each measurement. All of these novel methods for glucose monitoring still have unresolved hurdles. For example, a strong correlation for each biofluidbased measurement against the glucose level in blood plasma is yet to be established, and the correlation may differ for each individual. Nevertheless, these painless noninvasive methods are quite promising because patients with diabetes can monitor their glucose levels more easily and conveniently. The issue with their quality of life, particularly with potential trauma from needles involved in glucose monitoring, is expected to be resolved with more efficient and patient-friendly methods for diabetes management.
Principles of Enzymatic Glucose Sensing

Generations of Enzyme-Based Glucose Sensors
Enzymes have long been key components for building a glucose sensor, and their well-known mechanism of glucose processing constitutes the chemical principle of a glucose sensor. Biological enzymes react with glucose rapidly owing to their catalytic turnover, and the direct oxidation of glucose is energetically favorable. Among the families of enzymes associated with glucose metabolism, glucose oxidase (GO x ) is widely employed. [23] In principle, GO x oxidizes glucose to yield gluconic acid and hydrogen peroxide (H 2 O 2 ) via the following reaction
The first generation of GO x -based sensors monitors the O 2 consumed or H 2 O 2 produced, which react with electrodes to indicate the amount of glucose consumed (Figure 2a) . A high positive overpotential above 1 V versus Ag/AgCl is applied to detect the analytes directly, [55] but the high overpotential also facilitates side reactions such as oxidation of ascorbic acid, acetaminophen, uric acid, and lactic acid, thereby hampering the selectivity toward the target analytes. Additional mediators have been devised to increase the selectivity of the assay by lowering the overpotential and minimizing the oxidation of interfering species. The incorporation of platinum nanoparticles (Pt NPs) increases the sensitivity of glucose detection by favoring the selective oxidation of H 2 O 2 ( Figure 2b ). [56] Although Pt is highly reactive toward H 2 O 2 , the high reaction potential of the electrode remains a drawback. To resolve the overpotential issue, Prussian blue (PB) is incorporated as an electrocatalytic mediator to lower the reaction potential to near 0 V versus Ag/ AgCl (Figure 2c ). [57] Unlike Pt-based glucose sensors, PB-based glucose sensors utilize the reduction of H 2 O 2 . In the cyclic voltammograms (CVs), H 2 O 2 is reduced at negative potentials, and the current increases proportionally to the increasing concentration of H 2 O 2 .
The second-generation GO x -based sensors feature redox mediators that interact directly with enzymes ( Figure 2a ). For example, ferrocene is incorporated as a diffusional electron mediator that contacts GO x in the electron exchange process. [58, 59] Electrodes containing ferrocene and GO x experience an increase in current as glucose is introduced (Figure 2d ). [60] However, common mediators of ferrocene or ferricyanide derivatives are not recommended for in vivo devices because of their potential leaching and the resulting toxicity issues.
The third-generation GO x -based sensors use engineered enzymes whose structures are modified to facilitate the direct electron exchange between electrodes and embedded enzymes (Figure 2a) . [61] Nanostructured electrodes, such as electrodes treated with carbon nanotubes, can be coupled to GO x so that the electrochemically active flavin adenine dinucleotide (FAD; subunit of the enzyme) can transfer electrons directly to the electrodes. For example, the 1D hierarchically structured TiO 2 (1DHS TiO 2 ) electrode exhibits redox peaks of FAD/FADH 2 in CV, resulting from the direct electron transfer between the 1DHS TiO 2 electrode and coupled enzymes (Figure 2e ). [62] Although a considerable amount of progress has been made since the introduction of electrocatalytic mediators and structurally modified enzymes for the direct electron transfer, it may be noted that the electrochemical detection of byproducts remains the foundation of glucose sensing. A majority of commercial sensors and related studies rely on the first-and second-generation GO x -based techniques, and the requirement for an O 2 supply has been resolved with semipermeable membranes, which can be manufactured easily and inexpensively. Nevertheless, advanced sensor designs capable of oxygen-free, selective, and energetically efficient detection of glucose are highly desired.
Glucose-Dehydrogenase-Based Glucose Sensors
In addition to GO x , another enzyme family of glucose dehydrogenases (GDHs) has been used as a key material of the electrochemical reaction for glucose sensors. In terms of the reaction mechanism, GDH-based sensors can be classified by their various cofactors, ranging from tightly bound FAD or pyrroloquinoline quinone (PQQ) to unbound nicotinamide adenine dinucleotide (phosphate) [NAD(P)]. While GO x utilizes O 2 as an external electron acceptor, GDHs are unable to utilize O 2 , thereby avoiding the issue of O 2 supply (Figure 2f ). Therefore, GDH-based amperometric detection is independent of the O 2 concentration (Figure 2g ). [63] However, FAD/PQQ-GDH has a broad substrate specificity and catalyzes other analytes in the blood such as maltose. Protein engineering of the enzymes has helped eliminate the enzymes' activity toward other species and improve substrate specificity. [64] [65] [66] [67] Because the cofactor NAD(P) is not structurally bound to GDH, exogenous NAD(P) needs to be supplied (Figure 2h ). [68] However, NAD(P)H should not be [57] Copyright 2015, The Royal Society of Chemistry. d) CVs of ferrocene modified electrode in the absence and presence of glucose. Reproduced with permission. [60] Copyright 2015, The Royal Society of Chemistry. e) CVs of 1DHS TiO 2 /Nafion-modified (black dashed line), GO x /Nafion-modified (navy dotted line), and GO x /1DHS TiO 2 /Nafion-modified (red solid line) glassy carbon electrode measured in 0.1 m nitrogensaturated phosphate-buffered saline (PBS) solution (pH 7.4). Reproduced with permission. [62] Copyright 2011, American Chemical Society. f) Schematic illustrations of the sensing mechanism of FAD/PQQ-GDH (left) and NAD(P)-GDH (right) glucose sensor. g) Amperometric responses of PQQ-GDH glucose biosensor in determination of concentration of glucose in 0.1 m phosphate buffer (pH 7) at the conditions of ambient air (○), deaeration with N 2 gas (•), and saturation with O 2 gas (∆). Reproduced with permission. [63] Copyright 2010, MDPI. h) CVs of NAD(P)-GDH modified electrode in the absence (black dashed line) and presence (black solid line) of 50 × 10 −3 m NADH. Reproduced with permission. [68] Copyright 2016, The Royal Society of Chemistry.
oxidized directly within the sensor because the direct oxidation of NAD(P)H may beget spontaneously polymerized oxidation products, which would increase the overpotential and fouling of the electrodes significantly. Therefore, electrocatalytic mediators are employed to lower the applied potential to the extent that NAD(P)H is not oxidized. Although GDH has the advantage of operating independently of the O 2 concentration, it is strictly limited by its substrate specificity and often prone to reaction with other biomarkers (e.g., maltose), resulting in the overestimation of glucose readings. [69] [70] [71] Therefore, advanced protein engineering of GDH is required to minimize such potential errors from intrinsic enzymatic reaction pathway and to increase the reliability of glucose sensing via GDH.
Materials, Fabrication Processes, and Application Examples of the Electrochemical Glucose Sensor
To produce a practically applicable glucose sensor incorporating the basic glucose detection principles using enzymes introduced in Figure 2 , designation of reliable and efficient materials and fabrication processes are crucial. Novel material candidates and fabrication strategies have been suggested, and various types of glucose sensing systems have been introduced.
Materials for the Electrochemical Glucose Sensor
The electrochemical glucose sensor consists of working electrodes, counter electrodes, and reference electrodes. With these electrodes, the concentration of glucose is measured by the amperometric method, which monitors the current flowing between the working and counter electrodes. For the optimized performance of the electrodes within a sensor, different material candidates must be employed depending on the mode of the enzymatic reaction that the electrodes measure ( Figure 2 ) and the range of the target glucose concentrations. Moreover, the selectivity and sensitivity of the reaction rely heavily on the features of the working electrode. Thus, the design of the electrode should be articulate from the designation of base materials to the engineering of its surface structure.
Generally, sensitivity can be modulated by adjusting the surface area of the working electrode (Figure 3a) . [50] Porous electrodes tend to exhibit a higher sensitivity than planar electrodes because porous electrodes have a larger surface area available for electrochemical reaction with the reactants (Figure 3b ). [72] [73] [74] [75] [76] However, the production of a structured electrode requires an additional fabrication process, and thus the porous working electrode is commercially feasible only for high-precision devices with which a significantly low target range of glucose must be measured. Another critical factor that determines the quality of the electrode in glucose measurement is the immobilization of enzyme layer on the electrode, since a stably mounted enzyme on the electrode leads to reliable performance of the electrode in long-term operation (Figure 3c ). [50] For stable immobilization, the enzyme is crosslinked with hydrogels (e.g., chitosan and gelatin), nanomaterials (e.g., carbon nanotubes and graphenes), and other stabilizers (e.g., bovine serum albumin) via chemical and physical linkages (Figure 3d ). [77] [78] [79] Furthermore, the layer of electrocatalytic mediator also serves as an important factor that determines the selectivity and sensitivity (Figure 3e ). [80] [81] [82] [83] [84] The mediator should selectively react with the byproducts after the enzyme specifically oxidizes or dehydrogenizes glucose. Considering the target glucose concentration, an appropriate amount of mediator should be functionalized. For example, a thin PB film can exhibit both high sensitivity and selectivity owing to its strong and stable electrocatalytic activity at low operation potential, and it is therefore advantageous for detecting low concentrations of H 2 O 2 in sweat for glucose detection (Figure 3f ). [48] On the other hand, a thick PB film has a lower sensitivity at low concentrations but a higher linear response range makes it more suitable for detecting high concentrations of H 2 O 2 . In addition, a porous membrane (Figure 3g ) on the outer surface of the functionalized layers (e.g., Nafion) helps the immobilization of the enzyme and screens out molecules with the same electrostatic charge as the membrane (e.g., negative charges for Nafion) that may interfere with the glucose sensing (Figure 3h ). [85] [86] [87] [88] 
Fabrication Processes for the Electrochemical Glucose Sensor
Several specific fabrication processes may be required to accommodate glucose sensors within appropriate device formats once target fluids and glucose concentration ranges are determined. The fabrication process consists of electrode preparation and surface functionalization. The screen printing method is a widely used method to make electrochemical sensors because it can conveniently pattern an electrode with various functional materials in slurry forms by the applying appropriate designs on a screen (Figure 3i ). [89] [90] [91] [92] In addition, conventional semiconductor fabrication processes can also be used for preparing the sensor array (Figure 3j ). [93] [94] [95] [96] [97] A pronounced advantage of this method for producing an integrated sensor system is its high fabrication resolution. More importantly, the design of a device's main body must be optimized according to its mode of use. For example, when a glucose sensor is envisioned to be wearable, [98] [99] [100] [101] [102] the main device should have soft, [103] [104] [105] [106] [107] thin, [108] [109] [110] [111] [112] and stretchable [113] [114] [115] [116] [117] features so that it conforms to the body surface and endures physical strain, making it convenient to wear and stable even against physical perturbation of skin contact. Many device design strategies are used to exhibit such properties. For instance, introducing wavy structures to interconnection of the sensor enables bending and stretching of the sensor via contraction and elongation of the buckling. The fractal/serpentine structures enable large scale stretchability compared to simple wavy structures. In addition, to minimize physical strains induced to the device, active layers are located in the neutral mechanical plane in which compressive and tensile strains are counter-balanced.
After device fabrication, surface functionalization of the working electrode with electrocatalytic mediators and enzymes is required for sensitive and selective glucose detection. Several methods may be employed for the functionalization. The electroplating method is commonly used because it can selectively functionalize only the electrode region on which the electric current flows (Figure 3k ). [118, 119] Therefore, this method can be used to apply various electrochemical sensors of different materials on a desired region even when multiple sensors are integrated in a small area. In addition, this method can be used to make porous electrodes and deposit mediators with a desired thickness. The drop casting method using a micropipette is a simple protocol for surface functionalization, but it is difficult to functionalize only a desired area with a precisely controlled thickness (Figure 3l ). [120] Therefore, drop casting is used only to immobilize the enzyme and the porous membrane on the working electrodes where precision and high resolution are not crucial. Dip coating is another method for surface functionalization and is generally used as the final treatment (Figure 3m) . [120] The electrode treated with enzyme is immersed in a solution of reagents such as glutaraldehyde to undergo chemical crosslinking. Then, it is rinsed with distilled water to wash off enzymes that are not stably crosslinked, because unstably adsorbed enzymes would hinder the reliable operation of the glucose sensor in the long-term. [50] Copyright 2017, AAAS. c) An SEM image of stably immobilized enzyme layer. Reproduced with permission. [50] Copyright 2017, AAAS. d) Schematic illustrations of enzyme linking with electrode. Reproduced with permission. [77] Copyright 2010, Wiley-VCH. e) An SEM image of PB catalytic mediator layer. Reproduced with permission. [49] Copyright 2016, Nature Publishing Group. f) Responses of lactate (blue line) and glucose (brown line) sensors with different thickness of PB deposited. Reproduced with permission. [48] Copyright 2016, Nature Publishing Group. g) An SEM image of porous membrane for encapsulation. Reproduced with permission. [85] Copyright 2016, Elsevier. h) Responses of glucose sensor to glucose, acetaminophen, and H 2 O 2 in the absence (upper line) and presence (lower line) of Nafion membrane. Reproduced with permission. [87] Copyright 1994, American Chemical Society. i) An optical image of screen printed electrode. Reproduced with permission. [89] Copyright 2016, Nature Publishing Group. j) An optical image of electrode fabricated by semiconductor fabrication. Reproduced with permission. [50] Copyright 2017, AAAS. k) An optical image of electrodeposition for selective functionalization. l) An optical image of drop casting for functionalization. Reproduced with permission. [120] Copyright 2016, Wiley-VCH. m) An optical image of dip coating for crosslinking/rinsing of functionalized surface. Reproduced with permission. [120] Copyright 2016, Wiley-VCH. n) Representative application processes of glucose sensor: painful invasive method (top left), painless invasive method (top right), noninvasive method with active extraction of biofluids (bottom left), and noninvasive method with passive collection of biofluids (bottom right). Reproduced with permission. [12, 121, 122] 
Application Examples of the Electrochemical Glucose Sensor
Although physical and electrophysiological sensors can perform measurements immediately after contacting the body, the electrochemical glucose sensor must be exposed to biofluids containing glucose for measurement at certain time points. Therefore, for the practical application of the biofluidic sensors, the collection and analysis of biofluids are important. Glucose analysis directly from the blood samples is the most accurate method for measuring the glucose level compared to indirect methods using other biofluids because the glucose concentration in the blood is higher than in other biofluids (Figure 3n , top left). However, the process of blood collection is painful, and thus, alternative methods have been explored. To reduce pain, a microneedle sensor that subcutaneously monitors the glucose concentration in the ISF has been developed (Figure 3n , top right). [121] In the case of noninvasive monitoring, the collection procedure of the target biofluids does not involve pain, but it is difficult to obtain inner body fluids owing to the robust skin barrier. With the application of electric fields, glucose in the ISF can be extracted iontophoretically and/or reverseiontophoretically and monitored (Figure 3n , bottom left). [122] In the cases of saliva, tears, and sweat, the target biofluids can be passively obtained by wearable and disposable devices. The devices should be able to detect relatively low concentrations of glucose in these biofluids compared with blood ( Figure 3n , bottom right), and therefore usually require high sensitivity and selectivity of the integrated sensors with nanostructured electrodes. [12] 5. Invasive Biofluid-Based Glucose Monitoring Devices
Strip-Type Glucose Sensor
To measure the concentration of blood glucose, the use of venous plasma is considered the gold standard because it accurately reflects the status of the glucose level in the circulatory system. [123] However, collecting the venous plasma with a needle is invasive. Furthermore, it is difficult to isolate the plasma from impurities and cannot be used by patients on their own. Therefore, the glucose level is commonly measured with capillary blood drawn from fingertips via a blood test strip. For user convenience, the strips have a multilayer capillary channel to take up the blood drop effectively and deliver the fluid to the sensors, enabling measurement with only a small amount of blood (Figure 4a) . [22] After sufficient amount of blood is drawn by the strip inserted in the glucometer, the device automatically analyzes the collected blood (Figure 4b) . [22] The time interval between the blood sampling and the glucose measurement is kept constant by this mechanism, ensuring more accurate detection. Because the International Federation of Clinical Chemistry and Laboratory Medicine recommends that the measured glucose concentration should correspond to that in the plasma, [124] [125] [126] the glucometer converts the glucose concentration in capillary whole blood into the concentration in the plasma. By measuring the alternating current impedance, the glucometer estimates the hematocrit ratio and applies this ratio to accurately convert the glucose level in the whole blood to that in the plasma (Figure 4c ). [127] [128] [129] [130] [131] [132] [133] Although the conversion factor increases the accuracy of the reported glucose level, glucose monitoring via a blood strip is still prone to errors (Figure 4d ). [134, 135] 
Implantable and Microdialysis-Type Glucose Sensors
To monitor blood glucose continuously, implantable sensors and microdialysis-type devices have been developed. The implantable glucose sensor has been associated with several problems, including a short lifetime and poor biocompatibility. Gough et al. addressed these issues by using a nonporous polydimethylsiloxane (PDMS) layer and the co-immobilization of excess catalase and demonstrated that the implanted device lasted for more than one year in animals (Figure 4e ). [26, 136] Because the implanted device was an oxymetry-type glucose sensor, the device was not free from problems such as oxygen deficit. [27] This issue was improved by regenerating half of the oxygen consumed by GO x with catalase and limiting the radial diffusion of glucose using a 2D membrane, resulting in an increased oxygen to glucose concentration ratio. [28] However, the sensor exhibited an inherent 10-min time lag between the actual concentration and the reported value (Figure 4f ) because the circulatory transport to and mass diffusion of glucose within local tissues are slow. [136] Intravenous microdialysis is a sampling technique in which a microdialysis probe with a semipermeable membrane is inserted into the vein. [137] [138] [139] The perfusate is then perfused continuously through the probe, and the glucose contained in the dialysate is detected by the connected glucose sensor (Figure 4g with courtesy from M Dialysis AB). As the sensor is distant from the probe, there is a 5 min delay before the dialysate reaches the sensor. [140, 141] As this 5 min delay is corrected, the concentration of dialysate glucose matches well with the reference concentration of blood glucose (Figure 4h ). [142] Nevertheless, the system requires that a probe be inserted into a vein and connected to a pump, lines, and the glucose sensor, and thus is unsuitable for users during physical activity. Therefore, intravenous microdialysis has limited applications, such as glucose monitoring for patients assigned to bed rest in an intensive care unit. [143, 144] Even though they are popular and well established, invasive approaches involving a finger-prick, surgery, and probe insertion are associated with pain and stress to their users. To meet the urgent need for the painless monitoring of glucose, less-invasive approaches have been studied.
Noninvasive Biofluid-Based Glucose Monitoring Devices
Tear-and Saliva-Based Glucose Monitoring
Glucose levels in biofluids such as tears, saliva, ISF, and sweat are correlated with that in the blood. [145] Therefore, many studies have focused on these biofluids to develop noninvasive sensors and methods for glucose monitoring. Contact-lens-type glucose sensors have been developed to monitor glucose concentrations in tears (Figure 5a) . [32] [33] [34] [35] For user' convenience, a lens-type sensor should not hinder the field of vision and should be wireless. Therefore, chips and antenna for wireless communication have been miniaturized and mounted on the lens. Notably, Kim et al. incorporated transparent graphene to the glucose sensor and antenna to minimize visual disturbance (Figure 5b ). [36] Their contact lens measured glucose with a GO x -linked fieldeffect transistor (FET)-type glucose sensor, and an external antenna coupled with the sensor read the change in the reflection coefficient of the antenna at a resonant frequency of 4.1 GHz (Figure 5c ). [36] Another major issue with the lens-type glucose sensor is power supply, and inductive links or radio frequency power transmission have been suggested to empower the sensor wirelessly. However, these solutions are not considered attractive because they require bulky equipment. Therefore, a recently developed alternative features a biofuel cell that utilizes ascorbate as the fuel (Figure 5d ). [37] Saliva is an attractive biofluidic analyte because it is easy to obtain samples via simple spitting. However, various impurities in the saliva from ingested food and digested metabolites may hinder the accurate measurement of the glucose concentration. Generally, glucose in the saliva can be measured after large biomolecules mixed in the saliva are filtered out (Figure 5e ). [146] [147] [148] In contrast, a mouthguard-type glucose sensor was designed to directly measure glucose in the saliva (Figure 5f ). [38, 39] For such design of the glucose sensor to be practical, the device should be made of biocompatible and nontoxic materials because the leaching of potential toxic components to the digestive system may cause serious illnesses. Along with the potential as a viable alternative for glucose measurement, saliva can serve as versatile biofluidic specimen because other clinically significant analytes, including lactate and cholesterol, can be measured simultaneously with glucose, thereby monitoring glucose in a more comprehensive context of lifestyle-related diseases (Figure 5g) . [40] The correlation between the levels of blood glucose and saliva glucose indicates that saliva is clinically relevant in terms of glucose monitoring (Figure 5h) . [41] However, there are limitations of tear-and salivabased systems, in that contact lenses and mouthguards are uncomfortable for long-term use, that they are associated with adverse effects to optical and dental conditions, and that tears and saliva are strictly site-specific (the eyes and mouth, respectively) and the amount of these biofluids is limited.
Interstitial Fluid-Based Glucose Monitoring
ISF contains glucose at a concentration similar to that of blood glucose, and ISF glucose can be monitored either continuously or intermittently. [149, 150] A continuous ISF glucose sensor measures glucose with a subcutaneous microdialysis probe (Figure 6a) or a microneedle (Figure 6b ). [145, 151] Among the two design candidates, the microneedle is more popularly used and has been commercialized. The microneedle sensor has a wireless communication unit that transmits the blood glucose level to the controller (Figure 6c ). Because the sensor continuously monitors glucose, it reflects the realtime changes in blood glucose more accurately (Figure 6d ). Using the monitored glucose profile, an accompanying closedloop therapeutic unit that injects insulin at hyperglycemic peaks and glucagon at hypoglycemic troughs can control blood Reproduced with permission. [22] Copyright 2008, American Chemical Society. b) Schematic illustration of electrode configuration of blood glucose monitoring strip, with W, C/R, and F referring to working, counter/reference, and fill detection electrodes, respectively. Reproduced with permission. [22] Copyright 2008, American Chemical Society. c) Amperometric responses of glucose sensor to glucose concentrations of 75.7 (a), 170.4 (b), 318.0 (c), and 462.0 mg dL −1 (d) at different hematocrit ratio. Reproduced with permission. [127] Copyright 2007, Springer Nature. d) Accuracy of blood glucose monitoring strip with capillary whole blood. Reproduced with permission. [135] Copyright 2016, Informa UK Limited. e) An optical image of implantable glucose sensor. Reproduced with permission. [136] Copyright 2010, AAAS. f) The delay response to an intravascular glucose tolerance test. Reproduced with permission. [136] Copyright 2010, AAAS. g) Schematic illustration of microdialysis catheter for glucose monitoring. Reproduced with permission. Copyright 2011, Linton Instrument. h) Clarke error grid of glucose levels of microdialysis-type glucose monitoring device. Reproduced with permission. [142] Copyright 2016, Annals of Intensive Care.
glucose effectively. [152] [153] [154] [155] [156] [157] [158] Due to the low O 2 concentration in the ISF, oxygen deficit can be a problem when a GO x -based glucose sensor is applied for a long time. To overcome this problem, commercialized products employ a glucose-limiting membrane to modulate the influx of glucose and consumption of O 2 .
An intermittent ISF glucose sensor operates by extracting glucose from the ISF with electrical stimulation, either iontophoretically [122, 159] or reverse-iontophoretically. [160] [161] [162] Iontophoresis is a technique that polarizes ions and polar molecules toward each electrode by applying a small amount of current to the skin. In the iontophoresis type, a sweat-inducing agent Adv. Healthcare Mater. 2018, 7, 1701150 Figure 5 . Tear-and saliva-based glucose monitoring system. a) An optical image of the contact-lens-type sensor, showing the electrical circuitry of the sensing system. Reproduced with permission. [32] Copyright 2015, Wiley-VCH. b) An optical image of the transparent contact lens sensor for glucose sensing. Reproduced with permission. [36] Copyright 2017, Nature Publishing Group. c) Wireless monitoring of glucose concentrations using glucose sensor in b) from 1 × 10 −6 m to 10 × 10 −3 m. Reproduced with permission. [36] Copyright 2017, Nature Publishing Group. d) Schematic illustration of self-powered contact lens for glucose sensing. Reproduced with permission. [37] Copyright 2013, American Chemical Society. e) Schematic of saliva sampling and monitoring process. Reproduced with permission. [146] Copyright 2015, Elsevier. f) An optical image of the mouthguard biosensor integrated with wireless amperometric circuit board. Reproduced with permission. [38] Copyright 2015, Elsevier. g) Variations of salivary metabolite between two healthy volunteers before and after intense physical exercise. Reproduced with permission. [40] Copyright 2016, Wiely-VCH. h) Correlation between fasting plasma glucose and fasting saliva glucose concentrations. Reproduced with permission. [41] Copyright 2013, Diabetes and Metabolism. [42] Copyright 2017, National Academy of Sciences. f) Comparison of the blood and sweat glucose levels of seven subjects during 12 h fasting and 1 h after glucose intake (30 g glucose). Reproduced with permission. [42] Copyright 2017, National Academy of Sciences. g) An optical image of GlucoWatch system, an iontophoretic sensing system for glucose Reproduced with permission. [43] Copyright 2001, Elsevier. h) An optical image of a glucose iontophoretic glucose sensor in tattoo-type format applied on a human subject' skin. Reproduced with permission. [45] Copyright 2015, American Chemical Society. such as pilocarpine is iontophorized into the skin to generate sweat, and the ISF glucose mixed in the sweat is measured (Figure 6e ). [42] At different points in a dietary regimen, the concentration of ISF glucose extracted iontophoretically has been shown to correlate closely with that of the blood glucose (Figure 6f ). [42] In the reverse iontophoresis type, glucose is directly extracted by applying an electric field. At physiological pH, the skin has a net negative charge, and Na + serves as the major current carrier, creating a predominant ionic flow toward the cathode. The nonpolar glucose is swept into the net convective flow to the cathode and is detected at the cathode. Meanwhile, interfering species such as ascorbic acid and uric acid are negatively charged and are isolated at the anode. A device called GlucoWatch based on this technology has been commercialized (Figure 6g ), [43, 44, 163] but it is associated with the following problems: application of an electric field causes skin irritation, additional calibrations using finger-prick blood tests are required, and sweating interferes with the measurement. In addition, GlucoWatch is unable to monitor glucose at short intervals because glucose is extracted and measured at separate times.
To overcome these drawbacks, a tattoo-type reverse iontophoresis glucose sensor that applies a lower electrical current and conforms to the skin was designed (Figure 6h ). [45] Although there is still room to improve the process for obtaining ISF, ISF glucose monitoring is a promising method because the correlation between blood and ISF glucose concentrations has been studied extensively, and ISF contains a higher amount of glucose than tears, saliva, and sweat.
Sweat-Based Glucose Monitoring
Sweat has advantages over other biofluids for use in noninvasive glucose monitoring because sweat glands are distributed throughout the body, and the sweat response is considered rapid enough to reflect the physiological conditions in the core body. Sweat is secreted onto the surface of the skin after isotonic secretion from the secretory coil of the sweat gland and NaCl reabsorption through the reabsorptive duct. [164] Because sweat glucose remains unabsorbed at this step, it can be readily measured by monitoring sensors (Figure 7a) . [47] Figure 7 . Sweat-based glucose monitoring system. a) Schematic illustration of sweat glucose monitoring. Reproduced with permission. [47] Copyright 2016, Nature Publishing Group. b) An optical image of multiplexed sweat monitoring sensor on a subject's wrist. Reproduced with permission. [48] Copyright 2016, Nature Publishing Group. c) An optical image of graphene-hybrid electrochemical device array on a subject's skin with perspiration. Reproduced with permission. [49] Copyright 2016, Nature Publishing Group. d) An optical image of the disposable strip for sweat analysis on a subject's skin with perspiration. Reproduced with permission. [50] Copyright 2017, AAAS. e) Real-time levels of glucose with or without systematic compensation for temperature difference of glucose sensor in 100 × 10 −6 m glucose solutions. Reproduced with permission. [48] Copyright 2016, Nature Publishing Group. f) Measurement of pH levels (N = 4) in the sweat from five subjects before and after a meal. Reproduced with permission. [50] Copyright 2017, AAAS. g) Monitoring of glucose and pH changes in vitro under hyperglycemia in artificial sweat. The pH-based glucose level correction showed the higher accuracy. Reproduced with permission. [49] Copyright 2016, Nature Publishing Group. h) One-day monitoring glucose concentrations in the sweat and blood of a subject using the device form c). Reproduced with permission. [49] Copyright 2016, Nature Publishing Group. i) Statistical analysis of the correlation between the sweat glucose concentrations and the blood glucose concentrations (R = 0.76 from Pearson's correlation test, r 2 = 0.57 from linear regression analysis). Reproduced with permission. [50] Copyright 2017, AAAS. j) Statistical analysis of the correlation between the sweat glucose concentrations and the blood glucose concentrations for two subjects (N = 6 for each subject). Reproduced with permission. [50] Copyright 2017, AAAS.
of sensors have been developed to conveniently monitor sweat glucose during exercise. Wearable wristband (Figure 7b ) and patch-type (Figure 7c ) sensors can continuously monitor the changes in sweat glucose by remaining attached to the skin for a long time. [48, 49] Disposable strip-type sensors, analogous to the blood strip in design, offer a simple monitoring of sweat glucose, as the fluidic capillary channel in the sensor strip takes up sweat efficiently (Figure 7d) . [50] Integrated systems of electrochemical sensing have also been developed to improve the accuracy of the detection of sweat glucose. While the temperature and acidity of the blood remain homeostatic, these parameters in the sweat may vary with the conditions of sweat generation, and the fluctuations may undermine the reliability of enzymatic detection. Sweat can be as acidic as pH 4-5 depending on the amount of secreted lactic acid, and its temperature is directly affected by the ambient temperature. To correct potential distortions of measurements by changes in temperature and pH, temperature and pH sensors integrated along with glucose sensors enhance the accuracy of glucose monitoring by providing realtime corrections of the measured glucose levels based on precalibrated data. An increase in temperature causes the glucose sensor to overestimate the measured glucose levels because higher temperatures increase the enzymatic activity. This temperature dependency of the glucose sensor can be corrected by integrating a temperature sensor (Figure 7e ). [48] In the case of sweat acidity, the pH value varies among individual subjects and is affected by dietary routines (Figure 7f ). [50] Therefore, the pH dependency can be similarly corrected via an integrated pH sensor (Figure 7g) . [49] A patch-type device (Figure 7c ) was designed to monitor the levels of sweat glucose shed by a subject for one day (Figure 7h) . [49] The daily profile of sweat glucose concentrations from the patch-type sensor corresponded with those from a commercial glucose assay. The measured trends of the sweat glucose levels also correlated closely with those of blood glucose concentration, as confirmed by statistical analysis (Figure 7i ). [50] For a more accurate estimation of blood glucose via sweat, the correlation factor for the glucose concentrations between blood and sweat should be established for each individual using a sufficient amount of data (Figure 7j ). [50] However, the requirement of sweating at each measurement time may be inconvenient or not feasible for many potential users. In addition, it is often necessary to clean the region of the skin on which the sweat is collected, as the residual glucose and exogenous contaminants may affect the measurement.
Conclusion
The development of glucose sensors encompasses combined research efforts on various aspects such as materials, fabrication processes, and electrochemical analyses. During the last 50 years, extensive progress has been made in the field of the glucose sensor development to enhance the capabilities and improve the reliability of measuring glucose in the body. As we witness the continuously growing number of diabetic patients, the demand rises for an efficient system of glucose monitoring as a part of personalized treatment and health management. Since diabetes is a chronic disease with severe to fatal complications but no direct cure so far, a closely monitored glucose level in the body in real-time is essential for diabetic patients. Although the development of personal blood glucometers has brought significant changes in healthcare for diabetes, there remain several limitations. As a point-of-care method, it is difficult to monitor glucose levels continuously, and abrupt but significant changes in blood glucose levels are often neglected. Above all, patients usually do not comply well with conventional treatments because of the pain and discomfort associated with the invasive monitoring process.
New materials, concepts, and engineering techniques evolve toward the development of noninvasive and patient-friendly monitoring systems of blood glucose. While latest improvements of invasive monitoring systems feature minimal amount of blood specimen for a personal glucometer and continuous and accurate monitoring via an implantable-type device, invasive methods are still not free from physical pain and inconvenience associated with the protocols. As a new generation of the glucose sensing, the noninvasive system can satisfy both patient-friendly paradigms and reliability of glucose detection. The upcoming studies on improving the novel noninvasive monitoring systems is likely to ensue with a growing popularity. As a number of studies confirmed the potential application of many alternative biofluids such as tears, saliva, ISF, and sweat as viable analytes for glucose monitoring, incorporation of painless monitoring devices and patient-friendly protocols will strengthen the feasibility of noninvasive systems readily adopted in commercial and medical applications. Indeed, the painless methods are still less accurate compared to direct blood glucose monitoring and are yet to establish a more reliable protocol against physiological variance among individuals. Particularly, development of noninvasive sensors still has a room for improvement in terms of immobilizing enzymes, increasing the sensitivity, and reinforcing the long-term stability of the sensors. Along with the technological aspects in the individual device level pending further research, the convenient design of the noninvasive glucose monitoring system and protocol associated with acquisition of biofluid specimen may also need to be refined to promote patient-friendliness. Consequently, continued efforts and novel approaches to establish a reinforced biofluid-based glucose monitoring whose reliability is comparable to that of blood-based system hold a great promise for convenient blood glucose monitoring in daily routine and represent a novel paradigm for diabetic healthcare in the future.
